" 316.28 
publication of orphan-drug designations. 
each month fda will update a publicly available cumulative posting of all drugs designated as orphan drugs. these postings will contain the following information: 
(a) the name and address of the sponsor; 
(b) the generic name and trade name, if any, or, if neither is available, the chemical name or a meaningful descriptive name of the drug; 
(c) the date of the granting of orphan-drug designation; 
(d) the designated use in the rare disease or condition; and 
(e) if the drug loses designation after august 12, 2013, the date of it no longer having designation. 

